Rationale and emerging strategies for immune checkpoint blockade in soft tissue sarcoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rationale and emerging strategies for immune checkpoint blockade in soft tissue sarcoma

Published:2018-05-03 Issue:19 Volume:124 Page:3819-3829
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Wisdom Amy J.¹,Mowery Yvonne M.²^ORCID,Riedel Richard F.³,Kirsch David G.¹²^ORCID

Affiliation:

1. Department of Pharmacology and Cancer Biology; Duke University Health System; Durham North Carolina

2. Department of Radiation Oncology; Duke University Health System; Durham North Carolina

3. Department of Medicine, Division of Medical Oncology; Duke University Health System; Durham North Carolina

Funder

National Institutes of Health

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.31517/fullpdf

Reference63 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014

2. PD-1 blockade using pembrolizumab in adolescent and young adult patients with advanced bone and soft tissue sarcoma [abstract];Scheinberg;J Clin Oncol.,2017

3. Recurrent chromosome aberrations in cancer;Mitelman;Mutat Res,2000

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neo-adjuvant radiation and intratumoral immunotherapy followed by surgery- NARIS trial for extremity soft tissue sarcoma;Future Oncology;2024-09-13

2. The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific Perspectives;International Journal of Radiation Oncology*Biology*Physics;2024-04

3. Stereotactic body radiation therapy for sarcoma pulmonary metastases;Radiotherapy and Oncology;2023-10

4. Biology and Management of High-Grade Myxofibrosarcoma: State of the Art and Future Perspectives;Diagnostics;2023-09-22

5. Identification of m5C-related molecular subtypes and prediction models in the prognosis and tumor microenvironment infiltration of soft tissue sarcoma;Heliyon;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3